Targeting therapy of hepatocellular carcinoma with doxorubicin prodrug PDOX increases anti-metastatic effect and reduces toxicity: a preclinical study.
J Transl Med
; 11: 192, 2013 Aug 21.
Article
in En
| MEDLINE
| ID: mdl-23961994
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Oligopeptides
/
Prodrugs
/
Doxorubicin
/
Carcinoma, Hepatocellular
/
Liver Neoplasms
/
Lung Neoplasms
Type of study:
Clinical_trials
Limits:
Animals
/
Humans
/
Male
Language:
En
Journal:
J Transl Med
Year:
2013
Document type:
Article
Affiliation country:
China
Country of publication:
United kingdom